PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.Securities Agreement • October 30th, 2023 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 30th, 2023 Company Industry JurisdictionTHIS PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 26, 2029 (the “Termination Date”), but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one share of Common Shares under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENT PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.Securities Agreement • November 22nd, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 22nd, 2022 Company Industry JurisdictionTHIS PLACEMENT AGENT PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) November 21, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one Common Share under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b). This Preferred Investment Option is being issued pursuant to that certain engagement letter, dated as of September
PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.Securities Agreement • November 22nd, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 22nd, 2022 Company Industry JurisdictionTHIS PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) ____________2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one Common Share under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b).
PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.Securities Agreement • September 14th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 14th, 2022 Company Industry JurisdictionTHIS PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, _______________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) ___________2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ________ shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one share of Common Shares under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENT PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.Securities Agreement • September 14th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 14th, 2022 Company Industry JurisdictionTHIS PLACEMENT AGENT PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) ____________2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one share of Common Shares under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b). This Preferred Investment Option is being issued pursuant to that certain engagement letter, dated as of Sept
PREFERRED INVESTMENT OPTION INMED PHARMACEUTICALS INC.Securities Agreement • June 6th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 6th, 2022 Company Industry JurisdictionTHIS PREFERRED INVESTMENT OPTION (the “Preferred Investment Option”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) ____________2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Preferred Investment Option Shares”) of Common Shares. The purchase price of one share of Common Shares under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b).